During the past decade, Urocentrum Praha, s.r.o. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Urocentrum Praha, s.r.o." are "Cancer" (1 trials), "Metastatic Castrate Resistant Prostate Cancer (mCRPC)" (1 trials), "Overactive Bladder" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Urocentrum Praha, s.r.o." in a lesser frequency.

Most popular intervention types in "Urocentrum Praha, s.r.o." are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abiraterone" (1 trials), "Apitolisib" (1 trials), "BAY1817080" (1 trials) and "Darolutamide (Nubeqa, BAY1841788)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urocentrum Praha, s.r.o." are 3 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Urocentrum Praha, s.r.o.". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Urocentrum Praha, s.r.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urocentrum Praha, s.r.o., 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".